GLSI
Greenwich LifeSciencesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
GLSI vs peer average
60/100
GLSI vs. peer average (C vs. D)
Grade spread
B 3 · C 2 · D 2 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CADL is the first available peer comparator.
Loose small-cap immunotherapy/oncology development peer with valuation driven mainly by clinical updates and capital access rather than current commercial cash flow.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GLSI
Greenwich LifeSciences
CADL
Candel Therapeutics
Grade
C
C
Momentum
4
88
Value
41
41
Sentiment
100
34
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs CADL
GLSI / CADL
Grade Position
In line
GLSI vs. peer average (C vs. D)
60/100
Momentum
4
CADLValue
41
GLSISentiment
100
GLSIRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GLSI
CADL is the first peer returned for this comparison set.